China Universal Asset Management Company’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Buy |
|
|||||
|
2025
Q1 | $396K | Sell |
|
|||||
|
2024
Q4 | $622K | Buy |
|
|||||
|
2024
Q3 | $802K | Buy |
|
|||||
|
2024
Q2 | $389K | Sell |
|
|||||
|
2024
Q1 | $548K | Buy |
|
|||||
|
2023
Q4 | $343K | Buy |
|
|||||
|
2023
Q3 | $72.7K | Buy |
|
|||||
|
2023
Q2 | $52.9K | Sell |
|
|||||
|
2023
Q1 | $42.6K | Buy |
|
|||||
|
2022
Q4 | $38.4K | Buy |
|
|||||
|
2022
Q3 | $35K | Buy |
|